# Octapharma Pharmazeutika Produktionsgesellschaft m.b.H., Vienna, Austria – FDA Inspections

Source: https://www.keypedia.com/companies/octapharma-pharmazeutika-produktionsgesellschaft-mbh/36184852-dad7-4350-8b6f-36d4527ba46f

> Inspection records and compliance data for Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. in Vienna. 5 FDA inspections on record, 2 Form 483s, last inspected December 16, 2022.

---

## Details

- Name: Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
- FEI Number: 3002809097
- Address Line 1: Oberlaaer Strase 235
- City: Vienna
- Country Name: Austria
- Address: Oberlaaer Strase 235, Vienna, Austria
- Country: Austria

## Related Documents

- [483 - Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. - Unknown Date](https://www.keypedia.com/records/483/octapharma-pharmazeutika-produktionsgesellschaft-mbh/4d9c00ff-d606-4bc0-8ecc-6140e7c41950) — source: FDA, date: Invalid Date
- FDA Inspection 1194258 - Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. - 2022-12-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2022
- [FDA Inspection 1090370 - Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. - 2019-04-16](https://www.keypedia.com/records/fda_inspections/octapharma-pharmazeutika-produktionsgesellschaft-mbh/7c81d0cc-ae0e-4e4a-8b55-0b944d85eeff) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 16, 2019
- [FDA Inspection 1002598 - Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. - 2017-01-17](https://www.keypedia.com/records/fda_inspections/octapharma-pharmazeutika-produktionsgesellschaft-mbh/dbc69e2f-7dc6-4686-823b-67e414e440a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2017
- FDA Inspection 918160 - Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. - 2015-03-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 5, 2015
- FDA Inspection 816229 - Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. - 2012-12-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2012

## Related Companies

- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [GlaxoSmithKline Vaccines Srl](https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/3b442668-2065-481f-bc35-a803bb376acc)
- [LifeSouth Community Blood Centers, Inc](https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893)
- [Corixa Corporation](https://www.keypedia.com/companies/corixa-corporation/540054c0-cf35-42d2-9056-a9ae897ff412)
- [Lonza Netherlands B.V.](https://www.keypedia.com/companies/lonza-netherlands-bv/f39deee8-be7f-41a8-b12e-d2cf810de4c1)
- [Humacyte Global Inc](https://www.keypedia.com/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b)
- [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)
- [GlaxoSmithKline Biologicals SA](https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e)

## Related Officers

- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [investigator](https://www.keypedia.com/people/yonggang-wang/5c7dd00f-f810-4f86-9c78-51ae7f4b8acd)